Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ASCO Scientific Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ASCO Scientific Program
(NASDAQ: IOVA) Delayed: 4.06 +0.15 (3.84%)
Previous Close $3.91    52 Week High $ 
Open $3.92    52 Week Low $ 
Day High $4.20    P/E N/A 
Day Low $3.91    EPS $ 
Volume 11,624,194